Table 4. Univariate and multivariate Cox regression analyses for outcomes in N+ adjuvant patients after matching (n = 66).
| OS | ||||
|---|---|---|---|---|
| Univariate | Multivariate | |||
| Factor | HR (95% CI) | p | HR (95% CI) | p |
| Lymphovascular invasion | ||||
| Absent | 1 | |||
| Present | 2.139 (0.741–6.174) | 0.160 | ||
| T | ||||
| T1 | 1 | |||
| T2 | 2.461 (0.836–7.244) | 0.102 | ||
| T3 | 2.653 (0.332–20.935) | 0.359 | ||
| N | ||||
| N1 | 1 | |||
| N2 | 2.461 (0.836–7.244) | 0.102 | ||
| N3 | 2.635 (0.332–20.935) | 0.359 | ||
| Histological grade | ||||
| G1/G2 | 1 | 1 | ||
| G3 | 4.721 (1.534–14.523) | 0.007 | 4.721 (1.534–14.523) | 0.007 |
| Molecular subtype | ||||
| Luminal A | 1 | |||
| Luminal B | 9.676 (1.236–75.773) | 0.031 | ||
| HER2 | 4.154 (0.375–46.002) | 0.246 | ||
| Triple-negative | 10.333 (1.144–93.360) | 0.038 | ||
| DMFS | ||||
| Lymphovascular invasion | ||||
| Absent | 1 | 1 | ||
| Present | 3.299 (1.196–9.102) | 0.021 | 4.862 (1.649–14.335) | 0.004 |
| T | ||||
| T1 | 1 | |||
| T2 | 1.896 (0.553–6.498) | 0.309 | ||
| T3 | Undefined | 0.981 | ||
| N | ||||
| N1 | 1 | |||
| N2 | 1.800 (0.647–5.010) | 0.260 | ||
| N3 | 1.494 (0.191–11.666) | 0.702 | ||
| Histological grade | ||||
| G1/G2 | 1 | |||
| G3 | 2.090 (0.670–6.525) | 0.204 | ||
| Molecular subtype | ||||
| Luminal A | 1 | 1 | ||
| Luminal B | 5.355 (1.169–24.533) | 0.031 | 8.008 (1.675–38.294) | 0.009 |
| HER2 | 4.445 (0.813–24.313) | 0.085 | 3.862 (0.704–21.203) | 0.120 |
| Triple-negative | 5.770 (1.052–31.648) | 0.044 | 8.572 (1.530–48.028) | 0.015 |
G1 – well differentiated; G2 – moderately differentiated; G3 – poorly differentiated; N – lymph node metastasis